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Abstract 
Background  
In 2012, the Canadian Society of Cardiology indicated that patients supported with 
left ventricular assist device (LVAD) may drive a private vehicle 2 months after 
implantation, provided they are deemed clinically stable. Objective evidence 
supporting this recommendation is limited. We sought to compare data regarding 
driving habits in our patients following LVAD implantation. 
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Methods 
A standard questionnaire addressing driving patterns before and after LVAD 
implantation was sent to all living patients who had received an LVAD between 
January 2010 and January 2014. Ninety-four of 124 patients responded (average 
age 58 years, 69.2% men, 77.7% bridge to transplant).  
Results  
Prior to LVAD, all were living at home, 33% were employed, and 93% were driving. 
Sixty-nine percent indicated they drove after LVAD implantation; they were 
younger (56 vs 62 years, p=0.02) and had providers recommendation (p=0.004). 
Four of seven patients who had not driven before started driving (p<0.0001). Most 
patients (56%) initiated driving between weeks 2 and 8 after discharge. Ten (16%) 
patients experienced alarms while driving (6 related to batteries, 2 suction events, 
2 other); all were safely addressed. One patient had syncope and a motor vehicle 
accident without fatalities. Ninety four percent believed driving positively impacts 
quality of life, and 26% believed having an LVAD significantly affects driving ability.  
Conclusions  
Most patients returned to driving after LVAD implantation. A minority had LVAD-
associated alarms that were easily addressed. We suggest inclusion of driving 
habits in registries to provide clarity on the safety of driving while being supported 
with LVAD.  
Keywords: left ventricular assist device, end-stage heart failure, driving, 
automobiles, cars   
 
Introduction 
Left ventricular assist devices (LVADs) have demonstrated increased quantity and 
quality of life for both destination therapy and bridge to transplantation (BTT) 
indications. Due to the significant morbidity and mortality associated with the older 
models of pulsatile ventricular assist devices, Canadian Cardiovascular Society 
2003 guidelines and several European countries recommended that LVAD 
patients cease driving both private and commercial vehicles. As a result, several 
institutions advised patients to not drive after LVAD implantation. However, the 
current generation of continuous-flow devices are substantially more reliable, and 
thus in 2012, the Canadian Cardiovascular Society revised its recommendations to 
indicate that stable patients supported with LVAD may drive a private (not 
commercial) vehicle 2 months after implantation. This new recommendation was 
based on a “Risk of Harm” formula.1,2 Currently, only some institutions follow these 
guidelines, and as a result there is limited data on the driving patterns of patients 
 
The VAD Journal: https://doi.org/10.13023/VAD.2017.05 Page 3 of 12 
 
The VAD Journal: The journal of mechanical assisted circulation and heart failure 
supported with continuous-flow LVADs. Hence, we decided to study driving 
patterns and outcomes among patients supported with continuous-flow LVADs at 
our institution using a standard questionnaire. 
In order to understand the driving patterns of the patients before and after LVAD 
implantation, we collected data on demographics, social and employment status, 
clinical features and symptoms, driving habits, driving record, and personal 
preferences that affected their decision to drive a private vehicle. In addition, we 
obtained data regarding the driving instructions given by health care personnel at 
the time of discharge. Lastly, we assessed the association between quality of life 
and independent driving after LVAD implantation.  
Methods 
This study employed the use of an Institutional Review Board-approved study 
design and questionnaire to address patient driving patterns before and after 
LVAD implantation. The study population comprised all patients who received a 
continuous-flow LVAD (HeartMate II [Thoratec Corp., Pleasanton, CA] or 
HeartWare [HeartWare, Framingham, MA]) between January 2010 and January 
2014 at our tertiary care center, who were alive at the time of the study. An 
informed consent form and questionnaire were mailed to all the patients for 
voluntary enrollment in research. Enrolled patients were encouraged to complete 
the questionnaires and return the forms to our research personnel. We linked data 
obtained from the questionnaire with an established clinical LVAD database and 
analyzed factors associated with driving patterns after LVAD implantation. Data 
are analyzed using descriptive statistics. Continuous variables are expressed as 
mean±standard deviation (SD) or median±SD (when appropriate), and categorical 
variables are expressed as frequency and percentage (%).  
Results 
There were 156 patients who underwent LVAD implantation between January 
2010 and January 2014; 32 had died prior to our study and the remainder were 
eligible for this protocol. The questionnaires were mailed to the homes of the 124 
patients who were still alive and had received a continuous-flow LVAD. A total of 
94 of 124 patients (75.8%) responded to the survey; the average age of the 
respondents was 58 years, 69.2% were male, and 77.7% were supported for a 
BTT indication. The majority of the patients were INTERMACS 3 or 4 (62.7%) at 
the time of implantation, and 51% had ischemic cardiomyopathy. The average 
ejection fraction was 16%, and the average body mass index was 28.7. Before 
LVAD implantation, all 94 patients were living at home, 33% were employed, 98% 
had a valid driver’s license, and 93% (87) were driving. Of those who drove, 56% 
were driving daily for more than half an hour and 72% were driving more than 5 
miles daily. Of the 87 patients who drove, 7 had had motor vehicle accidents 
during the 12 months before LVAD implantation (Tables 1 and 2). 
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Table 1. Baseline Demographics 
Characteristics n=94 
Age  58.0±10.9 
Male sex 65 (69.2) 
Reason for LVAD 
BTT 73 (77.7) 
DT 17 (18.1) 
DT to BTT 4 (4.3) 
INTERMACS number 
1 7 (7.4) 
2 22 (23.4) 
3 21 (22.3) 
4 38 (40.4) 
5 4 (4.2) 
NA 2 (2.1)                                    
Diagnosis 
Idiopathic 38 (40.4) 
Ischemic 51 (54.3) 
Other 5 (5.3) 
Ejection fraction 16.0±4.8 
Body mass index 28.7±6.0 
Hemoglobin  8.4±2.7 
Creatinine  1.7±1.5 
Living arrangement 
Living at home 94 (100.0) 
Living in urban area 62 (68.1) 
Living alone 13 (17.1) 
Employed 31 (33.3) 
Pre-LVAD hospitalization 60 (65.2) 
Data are presented as n (%) or mean±standard deviation. 
BTT = bridge to transplant, DT = destination therapy. 
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Table 2 Baseline Driving Characteristics (n = 94) 
Before LVAD Implantation 
Characteristics n (%) 
Valid driver’s license 91 (97.9) 
Driving 87 (92.6) 
Afraid to drive 17 (18.3) 
Driving distance (n = 87)  
Less than 5 miles 24 (27.5) 
5-20 miles 47 (54.0) 
More than 20 miles 15 (17.2) 
NA 1 (1.2) 
Driving frequency (n = 87)  
Daily 43 (49.4) 
Less than 3 times/week 18 (20.6) 
More than 3 times/week 25 (28.7) 
NA 1 (1.2) 
Drive duration (n = 87)  
30 minutes 37 (43.8) 
30-120 minutes 44 (49.4) 
>2 hours 6 (6.7) 
Automobile accident (n = 87) 7 (8.0) 
ICD shock (n = 94)  
Yes 33 (35.1) 
No 50 (53.2) 
No ICD 11 (11.7) 
ICD = implantable cardioverter defibrillator,  
LVAD = left ventricular assist device, NA = not available. 
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After LVAD implantation, 86 patients were discharged to home and 8 patients were 
discharged after a rehabilitation stay. Most often, patients initially had assistance 
with their transportation needs from either a significant other (74%) or friends and 
relatives (17%). A total of 41 patients had assistance with driving for up to 2 
months. A total of 69 patients (77%) indicated that they remembered some sort of 
instructions given by their health care providers regarding driving, and 95% of 
them said they followed the instructions. After LVAD implantation, 12 patients 
returned to gainful employment. Out of all patients in our cohort, 59 (69%) 
admitted to driving (57 patients drove a car, 2 patients drove other vehicles) after 
LVAD implantation, and 38 drove more than 5 miles daily, 26 drove more than 30 
minutes daily, and 17 drove more than 100 miles at a time. Patients who drove 
after LVAD implantation were younger (56 vs 62 years, p=0.02), had a shorter 
length of hospital stay after LVAD implantation (13.7 vs 21.5 days, p=0.0134), and 
were more likely to have been advised by their health care provider that they may 
drive after LVAD implantation (p=0.004) (Table 3).  
After discharge, 7 patients (11%) started driving within 2 weeks and 36 (56.2%) 
drove within 2 to 8 weeks. Twenty-eight percent of the patients were afraid to start 
driving; however, 75% of all patients were eventually confident in driving after 
LVAD implantation. Twenty-six (30.2%) patients who were driving prior to LVAD 
implantation stopped driving after their surgery, and 4 (4.3%) who were not driving 
prior to LVAD started driving after the LVAD implantation (p<0.0001). Thirty-two 
percent of the patients who were not afraid of driving before the LVAD developed a 
fear of driving after LVAD implantation (p<0.01) (Table 3).  
Ten patients had alarms while driving: 6 related to batteries, 2 related to suction 
events, and 2 related to other reasons. All of these patients were able to safely pull 
over to the side of the road and address these alarms without consequence. One 
patient reportedly passed out while driving, resulting in a motor vehicle accident 
without permanent injuries or fatalities. Prior to LVAD implantation, 83 (88.3%) 
patients had an implantable cardioverter defibrillator (ICD), with 35.1% with a 
history of previous ICD shock. During the LVAD support period, only 2 patients had 
ICD shocks, and none occurred while driving.  
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Table 3. Post-LVAD Driving Data 
Characteristics (total n) n % 
Discharge driving instructions (n = 94) 
Driving instructions were provided 60 63.8 
N/A 3 3.2 
Physician advised that they can drive 69 73.4 
N/A 4 4.3 
Driving advice followed (n = 69) 61 88.4 
N/A 5 5.3 
Post-LVAD (n = 94) 
Had help with driving after LVAD   
Spouse 56 59.6 
Others 20 21.3 
N/A 18 19.1 
Patients who were driving after LVAD 64 68.1 
N/A 1 1.1 
Post-LVAD Drivers Only (n=64) 
Afraid to drive initially 20 31.0 
N/A 5 7.8 
Eventually confident to drive 48 75.0 
N/A 8 12.5 
Time to resuming driving   
≤2 weeks 7 10.9 
2-8 weeks 36 56.3 
>2 months 15 23.4 
N/A 6 9.4 
LVAD alarms while driving 16 25.0 
N/A 5 7.8 
Quality of life (n=94) 
Happy that they were advised not to drive 11 11.7 
N/A 1 1.1 
Driving impacts quality of life 88 93.6 
LVAD impacts driving ability 23 24.5 
N/A 6 6.4 
LVAD = left ventricular assist device, N/A = not available; remaining % 
represents the percentage of patients who responded “No” for the 
respective questions. 
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Among our cohort, 59 (62.7%) responded that they were 
satisfied with their ability to drive. Eighty-two (87%) patients 
replied that they would not be happy if they were advised not to 
drive at all, and 11 (12%) patients were happy they were advised 
not to drive. Eighty-eight (94%) patients responded that they 
believe driving impacts quality of life, and 23 (26%) believed that 
an LVAD affects driving ability (33% positively and 66% 
negatively). Eighty-eight percent of patients said they think that 
having an LVAD impacts the overall quality of life (of these, 76% 
felt it was a positive impact and 24% negative) (Table 4, Figure 
1).  
Table 4. Differences in Characteristics of Patients Who Continued to Drive 
and Who Stopped Driving After LVAD Implantation  
 Characteristics 
Drivers Who 
Stopped Driving 
After LVAD  
(n = 26, 30.2%) 
Drivers Who 
Continued 
Driving After 
LVAD  
(n = 60, 69.8%)  p 
Age (years) 62.4 ± 8.5 55.7 ± 11.5 0.0067 
Length of hospital stay  21.5 ± 15.8 13.7 ± 6.6 0.0134 
Male sex 20 (76.9) 41 (68.3) 0.4204 
Reason for LVAD    
BTT 19 (73.1) 48 (80.0) 0.6043 
DT 5 (19.2) 10 (16.7)  
DT to BTT 2 (7.7) 2 (3.3)  
INTERMACS number    
1 to 2 10 (40.0) 16 (27.1) 0.2430 
3 to 5 15 (60.0) 43 (72.9)  
Pre-LVAD employed 13 (50.0) 17 (28.3) 0.0528 
Pre-LVAD hospitalization 16 (61.5) 38 (64.4) 0.8002 
Pre-LVAD afraid to drive 7 (26.9) 6 (10.2) 0.0480 
Living in urban area 14 (58.3) 41 (69.5) 0.3297 
Doctor approved driving post discharge 14 (60.9) 50 (84.8) 0.0189 
Data are presented as n (%) or mean ± standard deviation. 
Bold represents statistical significance. 
BTT = bridge to transplant, DT = destination therapy, LVAD = left ventricular assist 
device. 
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Figure 1. Trends of driving and fear of driving before and after LVAD implantation. 
LVAD = left ventricular assist device. 
 
Discussion 
The current study shows that the majority of the patients (64 out of 94 [69%]) were 
able to drive after LVAD implantation, and 17 (26%) patients were able to 
continuously drive for more than 100 miles when needed. A few (n=10, 16%) 
patients had alarms while driving, mostly related to battery changes. Only 1 (1.5%) 
patient had syncope and a major motor vehicle accident; there were no fatalities. 
In another similar, although multicenter, study of 201 patients with LVADs, 85% of 
patients drove and 17% (29) had alarms, mostly related to battery changes (2 
were because of device malfunction); there were 5 (2.9%) vehicle accidents, but 
none were serious.3,4 Ambardekar et al. provided a survey to 83 ventricular assist 
device coordinators regarding their practice’s policy for LVAD-supported patients 
and driving and received responses from 33 of them.5 Of the respondents, 67% 
reported that their programs allowed patients to return to driving after they 
recovered from LVAD surgery, and 33% indicated that they did not allow LVAD 
patients to drive. Eighty-seven percent of centers counseled their patients not to 
drive if they had syncope.5  
Driving recommendations are based on the estimation of risk of harm while driving 
and the general consensus on the threshold of an acceptable risk of harm. The 
annual risk of harm while driving can be estimated by this formula: driving time (%) 
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× vehicle type (commercial or private) × annual risk of incapacitation × probability 
of injury or accident.2 In general, it is an acceptable standard for a patient with 
cardiovascular disease to drive if the risk of sudden cardiac incapacitation is less 
than 22% per year for a private vehicle driver or less than 1% for a commercial 
vehicle driver. Newer generation LVADs have demonstrated improved quality of 
life and low risk for sudden cardiac incapacitation.6 Published contemporary trials 
of continuous-flow LVAD devices and a large national data registry (INTERMACS) 
demonstrate that 1-year mortality among LVAD patients is approximately 20%, 
with one-third of deaths occurring in the first month. Most of the deaths during 
follow-up are not sudden and reflect progressive deterioration and physical 
debility. Estimates indicate an 8% to 12% rate of sudden cardiac incapacitation per 
year after LVAD implantation in this population, which is substantially less than the 
22% per year risk limit to drive a private vehicle.7 Hence, it was concluded that a 
stable LVAD patient can drive a private vehicle 2 months after implantation.1 
In our study, there were 2 ICD shocks after LVAD implantation. The American 
Heart Association (AHA)/Heart Rhythm Society (HRS) guidelines recommend that 
patients not drive for 6 months following an ICD discharge for ventricular 
tachycardia or ventricular fibrillation, and the European Heart Rhythm Association 
(EHRA) guidelines recommend they don’t drive for 3 months after such an event. 
Also, for primary prevention ICD implantation, AHA/HRS guidelines recommend 
patients should not drive for 1 week after implantation to allow for surgical recovery 
and EHRA guidelines recommend a 4-week period before a return to driving.8-10 
Appropriate shocks were reported in 24% of LVAD patients with ICDs for 
ventricular arrhythmias at one center, but the rate of syncope was unknown.11 
Ventricular fibrillation and ventricular tachycardia often result in syncope or near-
syncope among advanced heart failure patients not supported by LVAD, while 
those supported with LVAD often maintain consciousness or are minimally 
symptomatic despite these rhythm disturbances. Alarms related to suction events 
caused by either positional inflow cannula obstruction or low volume state often do 
not present with syncope. Suction events also are more common in the first month 
after LVAD implantation and improve with pump speed adjustment during follow-
up. Finally, cerebrovascular events occur in approximately 10% of LVAD-
supported patients and can cause motor function incapacitation. Two patients in 
our study had suction events while driving and neither had any syncope or motor 
vehicle accidents.  
Some limitations of the study include recall bias, which is common to similarly 
designed voluntary questionnaire studies. Furthermore, these responses only take 
into account views from patients who are ambulatory and presumably stable from 
a clinical perspective, and exclude those who have expired or may have suffered 
various incapacitating complications that made them unable to respond to these 
queries.  
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Conclusions 
Our data support the hypotheses that most patients who are ambulatory and 
stable can safely return to driving after LVAD implantation without an increased 
risk of motor vehicle accident and that the ability to drive substantially improves 
quality of life in the LVAD-supported patient population. The present study 
provides valuable information regarding driving patterns among a contemporary 
patient population supported with continuous-flow LVADs. The data add to 
established literature and may provide the basis for including lifestyle metrics to 
larger registries (eg., INTERMACS). Furthermore, driving safety assessed by the 
present protocol will extend and support current Canadian guidelines and 
conceivably alter other national society guidelines (AHA, American College of 
Cardiology, International Society for Health and Lung Transplantation). We believe 
the information obtained from this study may help change clinical practice 
recommendations and improve the quality of life for patients living with LVAD 
support.  
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